| Primary information |
|---|
| ID | 20606 |
| Pubchem ID | NA |
| Name | Lipoxin B4 |
| Description | Lipoxins (LXs) and aspirin-triggered lipoxin (ATL) are trihydroxytetraene-containing eicosanoids generated from arachidonic acid that are distinct in structure; formation; and function from the many other proinflammatory lipid-derived mediators. These endogenous eicosanoids have now emerged as found |
| Synonym | (5S;14R;6E;8Z;10E;12E;15S)-5;14;15-Trihydroxy-6;8;10;12-eicosatetraenoic acidChEBI(5S;6E;8Z;10E;12E;14R;15S)-5;14;15-Trihydroxyeicosa-6;8;10;12-tetraenoic acidChEBI(6E;8Z;10E;12E)-(5S;14R;15S)-Trihydr |
| Molecular Weight | 352.4651 |
| Formula | NA |
| IUPAC | (5S;6E;8Z;10E;12E;14R;15S)-5;14;15-trihydroxyicosa-6;8;10;12-tetraenoic acid |
| SMILE | CCCCC[C@H](O)[C@H](O)C=CC=CC=C/C=C/[C@@H](O)CCCC(O)=O |
| PDB ID | NA |
| KEGG | C06315 |
| HMDB ID | HMDB0005082 |
| Melting Point (Degree C) | NA |
| Water Solubility | NA |
| Drugbank ID | NA |
| Receptor | NA |
| Reference | HMDB
|